CD Biosynsis provides development and optimization services for the biosynthesis of C2 platform chemicals using genetic engineering and metabolic engineering technologies. We are committed to working with our partners to increase the yield of C2 platform chemicals through biosynthesis methods and to develop more biochassis that can be used for C2 platform chemical production.
Synthetic biology-driven C2 platform chemical production enables the conversion of biomass into a variety of basic chemical feedstocks, replacing unsustainable feedstocks with sustainable ones and reducing carbon emissions while maintaining chemical performance. Synthetic biology has distinct advantages over traditional chemical synthesis. Currently, synthetic biology approaches are available for the production of C2 platform chemicals including ethanol, ethylene, ethylene glycol, and acetic acid.
Figure 1. Representative pathways for the production of C2 platform chemicals. (Jang YS, et al., 2012)
Based on the synthetic biology platform, CD Biosynsis is able to use genetic engineering, metabolic engineering, protein engineering, enzyme engineering, and cell engineering strategies, combined with genomics, transcriptomics, and metabolomics analysis to help customers construct high-yield strains of C2 chemicals, improve the yield of target products, and optimize the production process of target products.
Through continuous exploration and optimization, we are able to help our customers build a wide range of microbial chassis for ethanol production, including bacterial, yeast, and algae strains. Also, based on our expertise, we are able to provide modification and optimization services for synthetic biology chassis.
We help our customers build bacterial and algal chassis for acetic acid production by using tools for the construction of biosynthetic pathways, tools for the optimization of metabolic pathways, and tools for the design of new functions and materials.
We combine synthetic biology with genetic engineering and metabolic engineering to provide ethylene production services and chassis optimization services for bacterial, fungal, yeast, and cyanobacterial chassis.
We can help our customers build microbial chassis for ethylene glycol production, regulate the metabolic pathways of ethylene glycol synthesis, and optimize glycol biosynthesis processes.
As a rapidly growing synthetic biology company, CD Biosynsis is committed to helping our customers meet the growing and evolving demand for bio-based chemical production. All of our deliverables will undergo a rigorous quality testing process to ensure the quality and reliability and can be delivered on time. If you are interested in our services or have any further questions, please do not hesitate to contact us.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.